Targeting the translational apparatus to improve leukemia therapy: roles of the PI3K/PTEN/Akt/mTOR pathway-Reference-Cited by-同舟云学术

Targeting the translational apparatus to improve leukemia therapy: roles of the PI3K/PTEN/Akt/mTOR pathway

Published:2011-03-25 Issue:7 Volume:25 Page:1064-1079
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Martelli A M,Evangelisti C,Chappell W,Abrams S L,Bäsecke J,Stivala F,Donia M,Fagone P,Nicoletti F,Libra M,Ruvolo V,Ruvolo P,Kempf C R,Steelman L S,McCubrey J A

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

http://www.nature.com/articles/leu201146.pdf

Reference193 articles.

1. Steelman LS, Abrams SL, Whelan J, Bertrand FE, Ludwig DE, Basecke J et al. Contributions of the Raf/MEK/ERK, PI3K/PTEN/Akt/mTOR and JAK/STAT pathways to leukemia. Leukemia 2008; 22: 686–707.

2. Martelli AM, Evangelisti C, Chiarini F, Grimaldi C, Manzoli L, McCubrey JA . Targeting the PI3K/AKT/mTOR signaling network in acute myelogenous leukemia. Expert Opin Invest Drugs 2009; 18: 1333–1349.

3. Sujobert P, Bardet V, Cornillet-Lefebvre P, Hayflick JS, Prie N, Verdier F et al. Essential role for the p110δ isoform in phosphoinositide 3-kinase activation and cell proliferation in acute myeloid leukemia. Blood 2005; 106: 1063–1066.

4. Tamburini J, Elie C, Bardet V, Chapuis N, Park S, Broët P et al. Constitutive phosphoinositide 3-kinase/Akt activation represents a favorable prognostic factor in de novo acute myelogenous leukemia patients. Blood 2007; 110: 1025–1028.

5. Zebedin E, Simma O, Schuster C, Putz EM, Fajmann S, Warsch W et al. Leukemic challenge unmasks a requirement for PI3Kδ in NK cell-mediated tumor surveillance. Blood 2008; 112: 4655–4664.

Cited by 169 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bioinformatics and validation reveal the potential target of curcumin in the treatment of diabetic peripheral neuropathy;Neuropharmacology;2024-12

2. The roles of phosphorylation of signaling proteins in the prognosis of acute myeloid leukemia;Pathology and Oncology Research;2024-07-05

3. Paclitaxel mediates the PI3K/AKT/mTOR pathway to reduce proliferation of FLT3‑ITD⁺ AML cells and promote apoptosis;Experimental and Therapeutic Medicine;2024-02-23

4. Prognostic Significance of Dual-Specificity Phosphatase 23 Expression in Acute Myeloid Leukemia;Journal of Blood Medicine;2024-02

5. In Silico, In Vitro, and In Vivo Evaluation of Caffeine-Coated Nanoparticles as a Promising Therapeutic Avenue for AML through NF-Kappa B and TRAIL Pathways Modulation;Pharmaceuticals;2023-12-18